Suppr超能文献

系统性 Toll 样受体刺激可抑制 NOD 小鼠的实验性变应性哮喘和自身免疫性糖尿病。

Systemic Toll-like receptor stimulation suppresses experimental allergic asthma and autoimmune diabetes in NOD mice.

机构信息

Université Paris Descartes, Paris, France.

出版信息

PLoS One. 2010 Jul 7;5(7):e11484. doi: 10.1371/journal.pone.0011484.

Abstract

BACKGROUND

Infections may be associated with exacerbation of allergic and autoimmune diseases. Paradoxically, epidemiological and experimental data have shown that some microorganisms can also prevent these pathologies. This observation is at the origin of the hygiene hypothesis according to which the decline of infections in western countries is at the origin of the increased incidence of both Th1-mediated autoimmune diseases and Th2-mediated allergic diseases over the last decades. We have tested whether Toll-like receptor (TLR) stimulation can recapitulate the protective effect of infectious agents on allergy and autoimmunity.

METHODS AND FINDINGS

Here, we performed a systematic study of the disease-modifying effects of a set of natural or synthetic TLR agonists using two experimental models, ovalbumin (OVA)-induced asthma and spontaneous autoimmune diabetes, presenting the same genetic background of the non obese diabetic mouse (NOD) that is highly susceptible to both pathologies. In the same models, we also investigated the effect of probiotics. Additionally, we examined the effect of the genetic invalidation of MyD88 on the development of allergic asthma and spontaneous diabetes. We demonstrate that multiple TLR agonists prevent from both allergy and autoimmunity when administered parenterally. Probiotics which stimulate TLRs also protect from these two diseases. The physiological relevance of these findings is further suggested by the major acceleration of OVA-induced asthma in MyD88 invalidated mice. Our results strongly indicate that the TLR-mediated effects involve immunoregulatory cytokines such as interleukin (IL)-10 and transforming growth factor (TGF)-beta and different subsets of regulatory T cells, notably CD4+CD25+FoxP3+ T cells for TLR4 agonists and NKT cells for TLR3 agonists.

CONCLUSIONS/SIGNIFICANCE: These observations demonstrate that systemic administration of TLR ligands can suppress both allergic and autoimmune responses. They provide a plausible explanation for the hygiene hypothesis. They also open new therapeutic perspectives for the prevention of these pathologies.

摘要

背景

感染可能与过敏和自身免疫性疾病的恶化有关。具有讽刺意味的是,流行病学和实验数据表明,一些微生物也可以预防这些疾病。这种观察结果是卫生假说的起源,根据该假说,过去几十年中,西方国家感染的减少是 Th1 介导的自身免疫性疾病和 Th2 介导的过敏性疾病发病率增加的原因。我们已经测试了 Toll 样受体(TLR)刺激是否可以重现感染原对过敏和自身免疫的保护作用。

方法和发现

在这里,我们使用两种实验模型,即卵清蛋白(OVA)诱导的哮喘和自发性自身免疫性糖尿病,对一组天然或合成 TLR 激动剂的疾病修饰作用进行了系统研究,这两种模型具有非肥胖糖尿病(NOD)小鼠的相同遗传背景,该小鼠极易发生这两种疾病。在相同的模型中,我们还研究了益生菌的作用。此外,我们还研究了 MyD88 基因缺失对过敏性哮喘和自发性糖尿病发展的影响。我们证明,当给予外来体时,多种 TLR 激动剂可预防过敏和自身免疫。刺激 TLR 的益生菌也可以预防这两种疾病。MyD88 无效的小鼠中 OVA 诱导的哮喘明显加速,进一步证明了这些发现的生理相关性。我们的研究结果强烈表明,TLR 介导的作用涉及免疫调节细胞因子,如白细胞介素(IL)-10 和转化生长因子(TGF)-β,以及不同的调节性 T 细胞亚群,特别是 TLR4 激动剂的 CD4+CD25+FoxP3+T 细胞和 TLR3 激动剂的 NKT 细胞。

结论/意义:这些观察结果表明,系统给予 TLR 配体可以抑制过敏和自身免疫反应。它们为卫生假说提供了一个合理的解释。它们也为预防这些疾病开辟了新的治疗前景。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f22/2900205/d260b3b1c670/pone.0011484.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验